Top Back to top


The EBMT invites pharmaceutical companies and other companies involved in the field of HSCT and Cellular Therapy to support its 48th Annual Meeting. Revenue from the Annual Meeting supports progressive research to help develop more life-saving and quality-of-life solutions in the fight against blood cancers and diseases.